A rationale for continuing mass antibiotic distributions for trachoma
Open Access
- 7 August 2007
- journal article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 7 (1), 91-10
- https://doi.org/10.1186/1471-2334-7-91
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The Unexpected Impact of aChlamydia trachomatisInfection Control Program on Susceptibility to ReinfectionThe Journal of Infectious Diseases, 2005
- Impact of Mass Distribution of Azithromycin on the Antibiotic Susceptibilities of Ocular Chlamydia trachomatisAntimicrobial Agents and Chemotherapy, 2005
- Mass Treatment and the Effect on the Load ofChlamydia trachomatisInfection in a Trachoma-Hyperendemic CommunityPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2005
- Mass Antibiotic Treatment and Community Protection in Trachoma Control ProgramsClinical Infectious Diseases, 2004
- Pesky trachoma suspect finally caughtBritish Journal of Ophthalmology, 2004
- Disappearance of Trachoma from Western NepalClinical Infectious Diseases, 2002
- Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infectionOphthalmic Epidemiology, 2001
- A Comparison of Oral Azithromycin with Topical Oxytetracycline/Polymyxin for the Treatment of Trachoma in ChildrenClinical Infectious Diseases, 1997
- Randomised controlled trial of single-dose azithromycin in treatment of trachomaThe Lancet, 1993
- Feasibility of multivariate density estimatesBiometrika, 1991